PureSafe Water Systems, Inc.

CIK:0000764839|SEC Filings

Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
SALES
SALES	$ 51,000	$ 0	$ 53,294	$ 0
COST OF SALES	2,111	0	2,111	0
GROSS PROFIT	48,889	0	51,183	0
OPERATING EXPENSES:
Compensation and related benefits, including stock-based compensation of $15,000 and $-0- for the three months ended June 30, 2015 and June 30, 2014, respectively	45,000	79,348	201,564	253,472
Insurance and medical benefits	4,416	17,332	33,957	60,850
Research and Development	2,826	0	4,857	676
Professional, legal and consulting fees, including stock based compensation of $-0-and $225,000 for the three months ended June 30, 2015 and June 30, 2014	9,630	331,696	89,126	858,563
Marketing	0	3,503	2,040	3,701
Occupancy	91,125	312,755	278,692	338,275
Other Administrative and General	9,991	40,154	38,661	86,807
Total operating expenses	162,988	784,788	648,896	1,602,344
LOSS FROM OPERATIONS	(114,099)	(784,788)	(597,713)	(1,602,344)
OTHER INCOME (EXPENSE)
Other Income	0	2,568	0	2,568
Interest expense, including interest to related parties of $18,845 and $15,447 for the three months ended September 30, 2015 and 2014, respectively	(220,027)	(258,421)	(1,053,463)	(716,326)
Gain on debt restructure	307,508	0	307,508	0
Change in fair value of derivative liability	(22,951)	(1,114,900)	1,588,711	(1,373,500)
Other (income) expense, net	64,530	(1,370,753)	842,756	(2,087,258)
Net Income (Loss)	(49,569)	(2,155,541)	245,043	(3,689,602)
Dividend on Preferred stock	(33,638)	(27,075)	(100,914)	(81,225)
NET INCOME (LOSS) APPLICABLE TO COMMON STOCKHOLDERS	$ (83,207)	$ (2,182,616)	$ 144,129	$ (3,770,827)
NET LOSS PER COMMON SHARE
Basic	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Diluted	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average common shares outstanding
Basic	2,548,778,041	1,124,200,104	2,446,300,595	1,104,569,253
Diluted	21,311,441,547	1,124,200,104	21,208,964,101	1,104,569,253

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ 245,043	$ (3,689,602)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Amortization of patents and trademarks	4,578	4,578
Interest expense- amortization of deferred financing	0	9,805
Professional fees- note conversions	600	1,974
Stock based compensation	45,000	652,810
Gain on debt restructure	(307,508)	0
Accretion of debt discount	429,937	327,058
Interest expense paid for late delivery settled through the issuance of common stock	5,000	17,898
Interest expense- derivative liabilities	384,113	157,700
Change in Fair value of warrants and embedded conversion option	(1,588,711)	1,373,500
Changes in operating assets and liabilities:
Accounts Receivable	(17,000)	0
Prepaid expenses and other current assets	(848)	32,780
Accounts payable, accrued expenses, accrued interest, accrued dividends, accrued compensation, accrued consulting and director fees and other current liabilities	569,162	648,879
NET CASH USED IN OPERATING ACTIVITIES	(230,635)	(462,620)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in unconsolidated subsidiary	0	0
NET CASH PROVIDED BY INVESTING ACTIVITIES	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash proceeds from convertible promissory notes	258,238	293,500
Cash proceeds from convertible promissory notes, officers and directors	3,490	11,300
Repayment of officers' and directors' loans	0	(11,300)
Cash received under preferred stock subscription	51	0
Cash proceeds from notes payable	0	196,800
Repayment of notes payable	(36,111)	(6,800)
NET CASH PROVIDED BY FINANCING ACTIVITIES	225,669	483,500
NET CHANGE IN CASH	(4,967)	20,880
Cash at beginning of period	4,967	2,199
Cash at end of period	0	23,079
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
New debt issued in Debt restructure	750,000	0
Convertible and non-convertible debt retired in debt restructure	359,895	0
Common stock issued for settlement of liabilities	27,111	86,179
Common stock issued for settlement of convertible debt	23,585	223,996
Reclassification of derivative liabilities to equity	527,295	291,900
Conversion of accrued liabilities to convertible notes	$ 0	$ 150,000
Preferred stock under debt restructure	1,199,045	0
Debt discount recorded on convertible debt and warrants accounted for as derivative liabilities	258,238	378,200

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
CURRENT ASSETS:
Cash	$ 0	$ 4,967
Accounts Receivable	17,000	0
Inventory	141,636	141,636
Prepaid expenses and other current assets	39,129	38,281
Total Current Assets	197,765	184,884
NON-CURRENT ASSETS
Property and equipment, net of accumulated depreciation of $44,449 at June 30, 2015 and December 31, 2014	0	0
Patents and Trademarks, net of accumulated amortization of $57,075 and $45,023 respectively	48,740	53,318
Other assets	23,390	23,390
Total Non-current assets	72,130	76,708
Total Assets	269,895	261,592
CURRENT LIABILITIES:
Accounts payable and accrued expenses	1,822,586	1,474,363
Accrued compensation	316,150	951,982
Accrued consulting and director fees	144,000	144,000
Notes payable to officer and director (including accrued interest of $0 and $170,710 at September 30, 2015 and December 31, 2014, respectively	17,500	560,760
Convertible promissory notes (including accrued interest of $489,953 and $327,807 and net of discount of $28,200 and $200,459, respectively at September 30, 2015 and December 31, 2014, respectively	2,123,343	1,772,571
Promissory notes payable (including accrued interest of $316,904 and $273,086 at June 30, 2015 and December 31, 2014, respectively	1,566,489	842,531
Fair value of detachable warrants and conversion option	764,057	2,354,600
Accrued dividends payable	190,328	190,328
Preferred stock to be issued	0	40,000
Common stock to be issued	0	5,000
Total Current Liabilities	6,944,454	8,336,135
Total Liabilities	6,944,454	8,336,135
STOCKHOLDERS' DEFICIT:
Preferred stock Series B, $0.00001 par value, 8% dividend: 10,000,000 shares authorized; 184,672 and 184,224 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively. Liquidation preference of $4,525,915 and $3,858,801 as of September 30, 2015 and December 31, 2014, respectively	2	2
Common stock at $0.00001 par value: 10,000,000,000 shares authorized; 2,548,778,041 and 1,743,981,226 shares issued at September 30, 2015 and December 31, 2014	25,488	17,439
Additional paid-in capital	45,317,106	44,170,214
Treasury stock, at cost, 4,400 shares	(5,768)	(5,768)
Accumulated deficit	(52,011,387)	(52,256,430)
Total Stockholders' Deficit	(6,674,559)	(8,074,543)
Total Liabilities and Stockholders' Deficit	$ 269,895	$ 261,592